Michael S. Lee, M.D. - MED - Ophthalmology Department, University of Minnesota
Text Size: Default Text Size Text Size Medium Text Size Large
Gold University of Minnesota M. Skip to main content.University of Minnesota.
Driven to Discover.
What's Inside


Ophthalmology Home

Make a Gift to Ophthalmology


 

 
  Home > Faculty > Michael S. Lee, M.D.
 

Michael S. Lee, M.D.


Professor
Departments of Ophthalmology, Neurology and Neurosurgery

Reinhardt L. and Ruth H. Schmidtke Chair in Neuro-Ophthalmology
Director, Neuro-Ophthalmology Service
Co-Director, Center for Thyroid Eye Disease
Michael S. Lee, M.D.

Contact Information



Phone: (612) 625-3553
Fax: (612) 626-3119

Email: mikelee@umn.edu

Address:
University of Minnesota
Department of Ophthalmology
420 Delaware St. SE, MMC 493
Minneapolis, MN 55455-0501

For Clinic, Appointment, and Referral information visit University of Minnesota Physicians

Patient Care

Dr. Lee sees patients with a variety of neuro-ophthalmic problems, including blepharospasm, hemifacial spasm, optic neuritis, ischemic optic neuropathy, double vision, eye pain, pseudotumor cerebri, thyroid eye disease and giant cell arteritis.

Research

  • Benign essential blepharospasm and hemifacial spasm
  • Optic nerve disease
  • Thyroid eye disease

Education and Training

Medical School: University of Pennsylvania School of Medicine
Internship: Presbyterian Medical Center, Philadelphia
Residency: Scheie Eye Institute, University of Pennsylvania
Fellowship: Massachusetts Eye and Ear Infirmary, Harvard Medical School

Honors and Awards

Best Teaching Faculty Award, Department of Ophthalmology University of Minnesota, 2009

Reinhardt L. and Ruth H. Schmidtke Chair in Neuro-Ophthalmology University of Minnesota, 2005

World Class Service Award, Cleveland Clinic Foundation, 2005

Distinguished Teaching and Service Award, Massachusetts Eye and Ear Infirmary, 2002

Society of Heed Fellows Fellowship Award, 2001

Heed Fellowship, 2001

ARVO/NEI Travel Fellowship Grant, 2000

Published Works

1. Berg J, Lee MS. Postoperative visual loss following ocular and non-ocular surgery, Clinical Ophthalmology, 2010;4:531-46.

2. Eichhorn K, Harrison AR, Bothun ED, McLoon LK, Lee MS. Ocular treatment of thyroid eye disease. Expert Rev Ophthalmol, 2010;5:313-25.

3. Lee, MS, Harrison AR, Grossman DS, Sloan FA. Risks of glaucoma among patients with benign essential blepharospasm, Ophthal Plast Reconstr Surg, 2010 Aug 9. [Epub ahead of print]

4. Lee MS, McKinney A, Brace JR, Santacruz K. Clinical and imaging features of fludarabine neurotoxicity. J Neuro-ophthalmol 2010;30:37-41.

5. Yomtoob DE, Dewan MA, Lee MS, Harrison AR. Comparison of pain scores with 30-gauge and 32-gauge needles for periocular botulinum toxin tyoe A injections. Ophthal Plast Reconstr Surg 2001;25:376-7.

6. Alcala-Barraza SR, Lee MS, Hanson LR, McDonald AA, Frey WH, McLoon LK. Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO and NT-4 to the CNS. J Drug Targeting, 2010;18:179-90.

7. Harrison AR, Lee MS, McLoon LK. Effects of elevated thyroid hormone on adult rabbit extraocular muscles. Invest Ophthalmol Vis Sci 2010;51:183-91.

8. Saylor M, McLoon LK, Harrison AR, Lee MS. Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. Arch Ophthalmol 2009;127:402-6.

9. Lee MS, Smith S, Galor A, Hoffman G. Antiplatelet and anticoagulant therapy in giant cell arteritis. Arthritis Rheum, 2006 Oct; 54(10):3306-9.

10. Bollinger K, Lee MS. Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge. Arch Ophthalmol 2005;123(3):400-1.